Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Illumina, Inc.

Market Cap 24.35B 21.01B 19.35B 18.16B 34.08B 2,306B 34.44B 229B 89.25B 1,127B 91.39B 89.45B 3,904B P/E Ratio 2026 *
35.6x
P/E Ratio 2027 * 29.5x
Enterprise Value 24.88B 21.46B 19.76B 18.55B 34.81B 2,356B 35.18B 234B 91.16B 1,151B 93.35B 91.36B 3,987B EV / Sales 2026 *
5.44x
EV / Sales 2027 * 5.01x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day+3.68%
1 week+2.82%
Current month+2.41%
1 month+16.51%
3 months+40.31%
6 months+23.74%
Current year+27.24%
1 week 155.55
Extreme 155.55
168
1 month 138.64
Extreme 138.64
177.22
Current year 112.65
Extreme 112.65
177.22
1 year 86.03
Extreme 86.03
177.22
3 years 68.7
Extreme 68.7
212.49
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 2023-09-24
Director of Finance/CFO 50 2024-04-14
Chief Tech/Sci/R&D Officer 55 2025-05-28
Director TitleAgeSince
Director/Board Member 65 2016-07-27
Director/Board Member 66 2016-12-31
Director/Board Member 65 2019-02-04
Date Insider Type Main position Quantity % Market Cap.
06-04Sell

Head of Human Resources

-783 0.0005%
06-01Sell

Head of Human Resources

-784 0.0005%
05-31
Corvex Management LP
SellCompany -235,000 0.1553%
Change 5-day change 1-year change 3-year change Capi.($)
+3.68%+2.82%+91.98%-18.53% 24.35B
+1.03%+0.19%+17.62%-8.92% 174B
+1.34%-1.31%-18.67%+28.93% 146B
+0.56%-1.74%-9.75%-24.05% 127B
-0.32%-3.69%-53.12%-12.29% 69.72B
+1.37%+0.37%+14.81%-4.69% 49.01B
+0.95%+0.34%-23.42%-33.71% 44.74B
+0.58%-3.58%+11.54%+9.37% 36.67B
+0.63%-2.08%+4.52%+36.51% 34.91B
-0.64%+0.14%-10.37%-17.53% 29.65B
Average +0.77%-1.74%+2.51%-4.49% 73.65B
Weighted average by Cap. +0.58%-1.83%-3.26%-3.20%

Financials

2026 *2027 *
Net sales 4.57B 3.94B 3.63B 3.41B 6.39B 433B 6.46B 42.94B 16.75B 211B 17.15B 16.78B 733B 4.83B 4.17B 3.84B 3.6B 6.76B 458B 6.83B 45.39B 17.7B 223B 18.13B 17.74B 774B
Net income 718M 619M 570M 535M 1B 67.95B 1.01B 6.74B 2.63B 33.19B 2.69B 2.64B 115B 861M 743M 684M 642M 1.21B 81.57B 1.22B 8.09B 3.16B 39.84B 3.23B 3.16B 138B
Net Debt 522M 450M 415M 389M 730M 49.43B 738M 4.9B 1.91B 24.14B 1.96B 1.92B 83.66B -160M -138M -127M -119M -224M -15.13B -226M -1.5B -585M -7.39B -599M -587M -25.61B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
26-06-15 166.89 $ +3.68% 2,094,441
26-06-12 160.97 $ -3.15% 1,498,534
26-06-11 166.21 $ +2.30% 1,487,031
26-06-10 162.47 $ +1.52% 2,757,735
26-06-09 160.03 $ +1.26% 1,455,111
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
160.97USD
Average target price
147.17USD
Spread / Average Target
-8.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!